(Q58096003)

English

A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients

article published in 2014

In more languages

Statements

scholarly article

0 references

A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients (English)

0 references

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

10

object named as

Dong-Young Noh

0 references

author name string

Moon-Woo Seong

1

0 references

Kyu Hyung Kim

3

0 references

Il Yong Chung

4

0 references

Eunyoung Kang

5

0 references

Jong Won Lee

6

0 references

Sue K. Park

7

0 references

Min Hyuk Lee

8

0 references

Jeong Eon Lee

9

0 references

Byung Ho Son

11

0 references

Hai-Lin Park

12

0 references

Sung Im Cho

13

0 references

Sung Sup Park

14

0 references

Sung-Won Kim

15

0 references

language of work or name

0 references

publication date

4 June 2014

0 references

Breast Cancer Research and Treatment

0 references

146

0 references

1

0 references

63-69

0 references

Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Triple-negative/basal-like breast cancer: review

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC).

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Genomic rearrangements in the BRCA1 and BRCA2 genes.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Triple-negative breast cancer: disease entity or title of convenience?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Triple-negative breast cancer: epidemiology and management options

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3006-7

21 January 2018

Identifiers

10.1007/S10549-014-3006-7

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58096003&oldid=2213751516"